About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

WHO Emphasises Safety of Pandemic Flu Vaccines

by VR Sreeraman on August 7, 2009 at 2:02 PM
Font : A-A+

 WHO Emphasises Safety of Pandemic Flu Vaccines

The World Health Organisation moved to reassure the public about the safety of pandemic flu vaccines on Thursday, emphasising that rigorous precautions were taken despite the speed of their development.

"The public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls," it said in a statement on its website.

Advertisement

Although many national regulators had fast-tracked procedures for approval, the swine flu vaccine was built on the same technology used to produce vaccines for frequently changing strains of seasonal influenza, the UN health agency underlined.

The streamlined process was established in the WHO's 2007 pandemic preparedness plan, agreed by health experts, regulators and vaccine makers to ensure that a flu vaccine for a pandemic strain was available quickly and in large quantities.
Advertisement

"During the 1957 and 1968 pandemics, vaccines arrived too late to be used as an effective mitigation tool during the more severe phases of the pandemics," the agency noted.

Influenza vaccines were not available in the deadliest flu pandemic on record in 1918, when an estimated 50 million people died.

The WHO advised all countries to carry on intensive testing and monitoring of vaccines even after they start to be administered.

While some serious adverse effects had been reported over the 60 years that flu vaccines have been used "these have been rare", it said.

Nonetheless, the WHO said "special safety issues will inevitably arise during a pandemic" because of the massive scale on which a vaccine would be administered.

"For example, adverse events too rare to show up even in a large clinical trial may become apparent when very large numbers of people receive a pandemic vaccine," the WHO added.

Countries have been ordering tens of millions of doses of vaccine for the A(H1N1) virus for mass vaccination campaigns, while clinical trials are usually carried out on thousands of volunteers.

Source: AFP
LIN
Advertisement

Advertisement
Advertisement

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

WHO Emphasises Safety of Pandemic Flu Vaccines Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests